Since administration of this antibody did not inhibit osteolysis, our results are consistent with the literature showing that inhibition of RANKL/RANK signaling by OPG does not inhibit the proliferation of tumor cells injected subcutaneously in mice [16]. This evidence concerns the gene TNFRSF11A and neoplasm.